BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

159 related articles for article (PubMed ID: 12695529)

  • 1. Glucocorticoid receptor antagonism by cyproterone acetate and RU486.
    Honer C; Nam K; Fink C; Marshall P; Ksander G; Chatelain RE; Cornell W; Steele R; Schweitzer R; Schumacher C
    Mol Pharmacol; 2003 May; 63(5):1012-20. PubMed ID: 12695529
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Glucocorticoid ligands specify different interactions with NF-kappaB by allosteric effects on the glucocorticoid receptor DNA binding domain.
    Garside H; Stevens A; Farrow S; Normand C; Houle B; Berry A; Maschera B; Ray D
    J Biol Chem; 2004 Nov; 279(48):50050-9. PubMed ID: 15355994
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The novel progesterone receptor antagonists RTI 3021-012 and RTI 3021-022 exhibit complex glucocorticoid receptor antagonist activities: implications for the development of dissociated antiprogestins.
    Wagner BL; Pollio G; Giangrande P; Webster JC; Breslin M; Mais DE; Cook CE; Vedeckis WV; Cidlowski JA; McDonnell DP
    Endocrinology; 1999 Mar; 140(3):1449-58. PubMed ID: 10067874
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The steroid antagonist RU486 exerts different effects on the glucocorticoid and progesterone receptors.
    Beck CA; Estes PA; Bona BJ; Muro-Cacho CA; Nordeen SK; Edwards DP
    Endocrinology; 1993 Aug; 133(2):728-40. PubMed ID: 8344212
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The steroid receptor antagonists RU40555 and RU486 activate glucocorticoid receptor translocation and are not excreted by the steroid hormones transporter in L929 cells.
    Pariante CM; Pearce BD; Pisell TL; Su C; Miller AH
    J Endocrinol; 2001 May; 169(2):309-20. PubMed ID: 11312148
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Identification of the functional domain of glucocorticoid receptor involved in RU486 antagonism.
    Lee MS; Choi HS; Kwon SH; Morita K; Her S
    J Steroid Biochem Mol Biol; 2009 Oct; 117(1-3):67-73. PubMed ID: 19635558
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Inhibition of gene expression by steroid hormone receptors via a negative glucocorticoid response element: evidence for the involvement of DNA-binding and agonistic effects of the antiglucocorticoid/antiprogestin RU486.
    Cairns C; Cairns W; Okret S
    DNA Cell Biol; 1993 Oct; 12(8):695-702. PubMed ID: 8397827
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Differential effects of the new glucocorticoid receptor antagonist ORG 34517 and RU486 (mifepristone) on glucocorticoid receptor nuclear translocation in the AtT20 cell line.
    Peeters BW; Ruigt GS; Craighead M; Kitchener P
    Ann N Y Acad Sci; 2008 Dec; 1148():536-41. PubMed ID: 19120154
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Dissociation of steroid receptor coactivator 1 and nuclear receptor corepressor recruitment to the human glucocorticoid receptor by modification of the ligand-receptor interface: the role of tyrosine 735.
    Stevens A; Garside H; Berry A; Waters C; White A; Ray D
    Mol Endocrinol; 2003 May; 17(5):845-59. PubMed ID: 12569182
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Inhibition of glucocorticoid-induced changes of Na(+), K(+)-ATPase in rat lens by a glucocorticoid receptor antagonist RU486.
    Xie GL; Yan H; Lu ZF
    Exp Eye Res; 2010 Oct; 91(4):544-9. PubMed ID: 20637751
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Effects of steroid hormones and antihormones in cultured cells.
    Jung-Testas I; Baulieu EE
    Exp Clin Endocrinol; 1985 Dec; 86(2):151-64. PubMed ID: 2936615
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Discovery of a Potent Steroidal Glucocorticoid Receptor Antagonist with Enhanced Selectivity against the Progesterone and Androgen Receptors (OP-3633).
    Du X; Eksterowicz J; Zhou H; Rew Y; Zhu L; Yan X; Medina JC; Huang T; Chen X; Sutimantanapi D; Jahchan N; Kong W; Sun J; Zavorotinskaya T; Ye Q; Fantin VR; Sun D
    J Med Chem; 2019 Jul; 62(14):6751-6764. PubMed ID: 31274313
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Glucocorticoid receptor antagonism reverts docetaxel resistance in human prostate cancer.
    Kroon J; Puhr M; Buijs JT; van der Horst G; Hemmer DM; Marijt KA; Hwang MS; Masood M; Grimm S; Storm G; Metselaar JM; Meijer OC; Culig Z; van der Pluijm G
    Endocr Relat Cancer; 2016 Jan; 23(1):35-45. PubMed ID: 26483423
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Differential modulation of androgen receptor transcriptional activity by the nuclear receptor co-repressor (N-CoR).
    Berrevoets CA; Umar A; Trapman J; Brinkmann AO
    Biochem J; 2004 May; 379(Pt 3):731-8. PubMed ID: 14744261
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The X-ray structure of RU486 bound to the progesterone receptor in a destabilized agonistic conformation.
    Raaijmakers HC; Versteegh JE; Uitdehaag JC
    J Biol Chem; 2009 Jul; 284(29):19572-9. PubMed ID: 19372222
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Formation of DNA adducts by cyproterone acetate and some structural analogues in primary cultures of human hepatocytes.
    Werner S; Kunz S; Beckurts T; Heidecke CD; Wolff T; Schwarz LR
    Mutat Res; 1997 Dec; 395(2-3):179-87. PubMed ID: 9465929
    [TBL] [Abstract][Full Text] [Related]  

  • 17. 11beta-alkyl-Delta9-19-nortestosterone derivatives: high-affinity ligands and potent partial agonists of the androgen receptor.
    Muddana SS; Price AM; MacBride MM; Peterson BR
    J Med Chem; 2004 Oct; 47(21):4985-8. PubMed ID: 15456242
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Differential targeting of brain stress circuits with a selective glucocorticoid receptor modulator.
    Zalachoras I; Houtman R; Atucha E; Devos R; Tijssen AM; Hu P; Lockey PM; Datson NA; Belanoff JK; Lucassen PJ; Joƫls M; de Kloet ER; Roozendaal B; Hunt H; Meijer OC
    Proc Natl Acad Sci U S A; 2013 May; 110(19):7910-5. PubMed ID: 23613579
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Does glucocorticoid receptor blockade exacerbate tissue damage after mineralocorticoid/salt administration?
    Rickard AJ; Funder JW; Morgan J; Fuller PJ; Young MJ
    Endocrinology; 2007 Oct; 148(10):4829-35. PubMed ID: 17640982
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The androgen receptor T877A mutant recruits LXXLL and FXXLF peptides differently than wild-type androgen receptor in a time-resolved fluorescence resonance energy transfer assay.
    Ozers MS; Marks BD; Gowda K; Kupcho KR; Ervin KM; De Rosier T; Qadir N; Eliason HC; Riddle SM; Shekhani MS
    Biochemistry; 2007 Jan; 46(3):683-95. PubMed ID: 17223690
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.